Market Cap 35.67M
Revenue (ttm) 0.00
Net Income (ttm) -29.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 76.44
Volume 446,400
Avg Vol 610,708
Day's Range N/A - N/A
Shares Out 10.19M
Stochastic %K 96%
Beta 1.32
Analysts Strong Sell
Price Target $11.50

Company Profile

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, which is in...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 7 4719 5700
Address:
18 Hasivim Street, Petah Tikva, Israel
Raxothus
Raxothus Jul. 17 at 3:50 PM
EOD FOLLOW-UP – 07/17/25 Tracking continuation watch from 07/16 based on today’s highs vs prior close ❌ $IPDN – Closed 2.55, weak push to 2.50, failed VWAP and trended lower. No continuation. ✅ $PYPD – Closed 3.76, hit 3.86 HOD, held VWAP all day. Slow but held range. ✅ $DPRO – Closed 5.15, hit 6.95 HOD. Pulled back but held VWAP. Solid range. ✅ $MEIP – Closed 3.87, hit 4.25 HOD, dancing around VWAP. Held most gains. ❌ $YHC – Closed 11.15, weak open, flushed to low 8s. No setup. Recap Total: 5 Winners: 3 Faders: 2 Accuracy: 60% ⚠️ Mixed action. No explosive moves, but $DPRO, $MEIP, and $PYPD held VWAP and offered controlled setups. No volume, no entry. No reclaim, no reason. #VWAP #SniperSetup #Continuation #SmallCaps #Accountability #DayTrading
0 · Reply
sxpl
sxpl Jul. 17 at 3:07 PM
$VLCN 👍🏽 $PYPD Tic Toc … ☝🏼
0 · Reply
huskyd97
huskyd97 Jul. 17 at 2:40 PM
$PYPD slow and steady climb. I like it!
0 · Reply
Raxothus
Raxothus Jul. 16 at 7:38 PM
EOD CONTINUATION WATCHLIST - 07/16/25 Focused on stocks that held VWAP and pushed into Power Hour with strength. $IPDN - 4.9% move with 7.2x volume, held VWAP and closed strong. Watching 2.55+ reclaim for clean continuation $PYPD - 5.7% move, micro float with 5.6x volume. Weak 2PM push but held range. Needs VWAP reclaim and volume over 3.07 $DPRO - Strong 18.5% day, 11.6% VWAP stretch, 7.0x volume. Watching 5.25+ breakout if volume returns $MEIP - 19.9% surge, held intraday highs into close, 6.4% VWAP stretch. Volume 8.9x average. Eyeing 3.85+ continuation $YHC - Exploded 150.0%+, massive 40.1% VWAP stretch. 37.9% push after 2PM confirms strength. High RSI (70.7), watching for gap and squeeze over 10.22 Looking for gap and VWAP hold tomorrow. Clean entries only, no hope trades. #VWAP #Continuation #SmallCaps #DayTrading #SniperSetup
0 · Reply
ZacksSCR
ZacksSCR Jul. 16 at 5:07 PM
$PYPD: Positive Topline Data From D-PLEX₁₀₀ Trial Contributes to Multiple Subsequent Benefits https://buff.ly/m5ts7l0
0 · Reply
wallstpirate
wallstpirate Jul. 16 at 4:26 PM
$PYPD Their assets. They already have their manufacturing plant ready too. Their slow release patented drug release is being looked at for chemo drugs too. The infection drug alone is potentially worth multiples of the curren tmarket cap by itself. The recent GLP-1 news could be a monster as we recently saw lilly pay 870m for a co that has the same type of slow realse drug. All this and just a little over 40m markt cap. Can you say cheap.
1 · Reply
WallStWireAds
WallStWireAds Jul. 16 at 3:22 PM
$PYPD https://venture-block.com/roth-capital-analyst-reiterates-9-price-target-for-polypid-following-entry-into-glp-1-market/
0 · Reply
wallstpirate
wallstpirate Jul. 16 at 2:57 PM
$PYPD The low float makes this a perfect stock that can run hard when people want in as there are only a few shares and some of the buys are big which tells me its not retail buying.
0 · Reply
Project_Profit
Project_Profit Jul. 16 at 2:23 PM
$PYPD things are getting exciting here! Where are all the BULLS at? GLP1 News is huge! $LLY is about to buy this company out for an easy grab $10 a share please!
2 · Reply
WallStWireAds
WallStWireAds Jul. 16 at 1:38 PM
$PYPD https://www.benzinga.com/pressreleases/25/07/ab46431241/polypids-game-changing-60-day-glp-1-platform-could-disrupt-100b-weight-loss-market
0 · Reply
Latest News on PYPD
PolyPid Ltd. (PYPD) Q1 2025 Earnings Call Transcript

May 14, 2025, 1:24 PM EDT - 2 months ago

PolyPid Ltd. (PYPD) Q1 2025 Earnings Call Transcript


PolyPid to Participate in The Citizens Life Sciences Conference

Apr 22, 2025, 7:00 AM EDT - 3 months ago

PolyPid to Participate in The Citizens Life Sciences Conference


PolyPid to Participate in the 37th Annual ROTH Conference

Mar 3, 2025, 7:00 AM EST - 4 months ago

PolyPid to Participate in the 37th Annual ROTH Conference


PolyPid Ltd. (PYPD) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 10:44 AM EST - 5 months ago

PolyPid Ltd. (PYPD) Q4 2024 Earnings Call Transcript


PolyPid Ltd. (PYPD) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 2:06 PM EST - 8 months ago

PolyPid Ltd. (PYPD) Q3 2024 Earnings Call Transcript


PolyPid Ltd (PYPD) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 1:25 PM EDT - 1 year ago

PolyPid Ltd (PYPD) Q2 2024 Earnings Call Transcript


PolyPid Ltd (PYPD) Q1 2024 Earnings Call Transcript

May 9, 2024, 10:38 PM EDT - 1 year ago

PolyPid Ltd (PYPD) Q1 2024 Earnings Call Transcript


PolyPid Ltd (PYPD) Q4 2023 Earnings Call Transcript

Feb 14, 2024, 11:13 AM EST - 1 year ago

PolyPid Ltd (PYPD) Q4 2023 Earnings Call Transcript


PolyPid Ltd. (PYPD) Q3 2023 Earnings Call Transcript

Nov 12, 2023, 1:08 AM EST - 1 year ago

PolyPid Ltd. (PYPD) Q3 2023 Earnings Call Transcript


Raxothus
Raxothus Jul. 17 at 3:50 PM
EOD FOLLOW-UP – 07/17/25 Tracking continuation watch from 07/16 based on today’s highs vs prior close ❌ $IPDN – Closed 2.55, weak push to 2.50, failed VWAP and trended lower. No continuation. ✅ $PYPD – Closed 3.76, hit 3.86 HOD, held VWAP all day. Slow but held range. ✅ $DPRO – Closed 5.15, hit 6.95 HOD. Pulled back but held VWAP. Solid range. ✅ $MEIP – Closed 3.87, hit 4.25 HOD, dancing around VWAP. Held most gains. ❌ $YHC – Closed 11.15, weak open, flushed to low 8s. No setup. Recap Total: 5 Winners: 3 Faders: 2 Accuracy: 60% ⚠️ Mixed action. No explosive moves, but $DPRO, $MEIP, and $PYPD held VWAP and offered controlled setups. No volume, no entry. No reclaim, no reason. #VWAP #SniperSetup #Continuation #SmallCaps #Accountability #DayTrading
0 · Reply
sxpl
sxpl Jul. 17 at 3:07 PM
$VLCN 👍🏽 $PYPD Tic Toc … ☝🏼
0 · Reply
huskyd97
huskyd97 Jul. 17 at 2:40 PM
$PYPD slow and steady climb. I like it!
0 · Reply
Raxothus
Raxothus Jul. 16 at 7:38 PM
EOD CONTINUATION WATCHLIST - 07/16/25 Focused on stocks that held VWAP and pushed into Power Hour with strength. $IPDN - 4.9% move with 7.2x volume, held VWAP and closed strong. Watching 2.55+ reclaim for clean continuation $PYPD - 5.7% move, micro float with 5.6x volume. Weak 2PM push but held range. Needs VWAP reclaim and volume over 3.07 $DPRO - Strong 18.5% day, 11.6% VWAP stretch, 7.0x volume. Watching 5.25+ breakout if volume returns $MEIP - 19.9% surge, held intraday highs into close, 6.4% VWAP stretch. Volume 8.9x average. Eyeing 3.85+ continuation $YHC - Exploded 150.0%+, massive 40.1% VWAP stretch. 37.9% push after 2PM confirms strength. High RSI (70.7), watching for gap and squeeze over 10.22 Looking for gap and VWAP hold tomorrow. Clean entries only, no hope trades. #VWAP #Continuation #SmallCaps #DayTrading #SniperSetup
0 · Reply
ZacksSCR
ZacksSCR Jul. 16 at 5:07 PM
$PYPD: Positive Topline Data From D-PLEX₁₀₀ Trial Contributes to Multiple Subsequent Benefits https://buff.ly/m5ts7l0
0 · Reply
wallstpirate
wallstpirate Jul. 16 at 4:26 PM
$PYPD Their assets. They already have their manufacturing plant ready too. Their slow release patented drug release is being looked at for chemo drugs too. The infection drug alone is potentially worth multiples of the curren tmarket cap by itself. The recent GLP-1 news could be a monster as we recently saw lilly pay 870m for a co that has the same type of slow realse drug. All this and just a little over 40m markt cap. Can you say cheap.
1 · Reply
WallStWireAds
WallStWireAds Jul. 16 at 3:22 PM
$PYPD https://venture-block.com/roth-capital-analyst-reiterates-9-price-target-for-polypid-following-entry-into-glp-1-market/
0 · Reply
wallstpirate
wallstpirate Jul. 16 at 2:57 PM
$PYPD The low float makes this a perfect stock that can run hard when people want in as there are only a few shares and some of the buys are big which tells me its not retail buying.
0 · Reply
Project_Profit
Project_Profit Jul. 16 at 2:23 PM
$PYPD things are getting exciting here! Where are all the BULLS at? GLP1 News is huge! $LLY is about to buy this company out for an easy grab $10 a share please!
2 · Reply
WallStWireAds
WallStWireAds Jul. 16 at 1:38 PM
$PYPD https://www.benzinga.com/pressreleases/25/07/ab46431241/polypids-game-changing-60-day-glp-1-platform-could-disrupt-100b-weight-loss-market
0 · Reply
wallstpirate
wallstpirate Jul. 15 at 10:11 PM
$GOSS $PYPD @Finnish_boy @HROWfan @StockScubaDiver Check this out PYPD just announced this am the development of a long-acting GLP-1 receptor agonist delivery platform capable of maintaining therapeutic levels for approximately 60 days from a single subcutaneous administration – potentially reducing injections from weekly to just six times yearly. (They have less than a 40m market cap ) Recent $870 Million Deal Validates Exactly What PolyPid Just Unveiled. The timing couldn’t be more striking. Just days ago, Eli Lilly announced a collaboration worth up to $870 million with Sweden’s Camurus to develop long-acting formulations of their incretin drugs. This follows Novo Nordisk’s $285 million deal with Ascendis Pharma for once-monthly GLP-1 technology last November. Read this article too. I doubled my shaes this am on news and it was actuallt down a nickel aand closed up. https://the10xradar.substack.com/p/polypid-the-biotech-that-broke-my
1 · Reply
TaxiBiotech_
TaxiBiotech_ Jul. 15 at 3:21 PM
$PYPD 💥The GLP‑1 Battle Continues Today! Hengrui. HRS9531 (GLP‑1/GIP): 19–23% weight loss in Chinese Ph3 study PolyPid $PYPD. 60‑day GLP‑1 delivery platform with linear release 🤔 Too much competition among similar molecules? #GLP1 #Obesity #biotech Follow me for more biotech & stocks
0 · Reply
WallStWireAds
WallStWireAds Jul. 15 at 12:48 PM
$PYPD https://thefinanceherald.com/nano-cap-polypid-unveils-60-day-glp-1-delivery-tech-as-pharma-giants-pay-billions-for-similar-solutions/
0 · Reply
WallStWireAds
WallStWireAds Jul. 15 at 12:20 PM
$PYPD https://www.globenewswire.com/news-release/2025/07/15/3115546/0/en/PolyPid-Unveils-a-Long-Acting-GLP-1-Receptor-Agonists-Delivery-Platform-Targeting-the-Diabetes-and-Weight-Loss-Market.html
0 · Reply
WallStWireAds
WallStWireAds Jul. 13 at 10:47 AM
$PYPD https://thefinanceherald.com/wall-street-analysts-think-polypid-a-35m-biopharma-player-is-significantly-undervalued-heres-why/
0 · Reply
sxpl
sxpl Jul. 8 at 7:14 PM
$PYPD In again 👊. Let’s see the next news
0 · Reply
WallStWireAds
WallStWireAds Jul. 8 at 12:27 PM
0 · Reply
11hundred
11hundred Jul. 7 at 11:46 AM
$APGE another $PYPD. Great news, quick hype then undervalued.
0 · Reply
11hundred
11hundred Jul. 7 at 10:17 AM
$APGE I hope this won't turn out like $PYPD
0 · Reply
WallStWireAds
WallStWireAds Jul. 6 at 8:47 PM
$PYPD https://newsblaze.com/business/finance/is-polypid-stock-undervalued-nasdaq-pypd_205280/
0 · Reply
WallStWireAds
WallStWireAds Jul. 5 at 7:12 PM
$PYPD Join PYPD's IR News channel to get latest announcements and news from the company https://t.me/PolyPidNews
0 · Reply
sxpl
sxpl Jul. 2 at 4:36 PM
0 · Reply